SEC Form 4 · accession 0001569706-18-000001
NYMOX PHARMACEUTICAL CORP · NYMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall J Lanham
Officer — General Counsel · Director
Period of report
Oct 28, 2018
Accepted (ET)
Nov 6, 2018 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001018735
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common | Oct 28, 2018 | P | 2,900 | $1.72 | A | 152,900 | D |
Table II — derivative securities
No Table II lines on this filing.